By Ben Glickman
Shares of Enanta Pharmaceuticals rose after the company said it had slashed its fiscal 2024 spending guidance.
The stock was up 21% to $10.78 on Tuesday. Shares have fallen 77% this year.
The…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here